The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3′-end formation by Sachchithananthan, Mythily et al.
The relationship between the prothrombin
upstream sequence element and the G20210A
polymorphism: the influence of a competitive
environment for mRNA 30-end formation
Mythily Sachchithananthan, Stan J. Stasinopoulos, Jeffrey Wilusz
1 and Robert L. Medcalf*
Monash University, Department of Medicine, Australian Centre for Blood Diseases, 6th Floor, Burnet Building,
AMREP, Commercial Road Prahran, Victoria 3181, Australia and
1Department of Microbiology, Immunology
and Pathology, Colorado State University, Fort Collins, CO 80523 USA
Received October 4, 2004; Revised December 27, 2004; Accepted January 24, 2005
ABSTRACT
The human prothrombin G20210A polymorphism
located at the 30 cleavage site of the mRNA results
in elevated plasma prothrombin levels and increased
risk of venous thrombosis. This polymorphism has
been shown to directly influence a variety of pro-
cesses related to prothrombin mRNA metabolism.
We have constructed plasmids that express the full-
length prothrombin mRNA that is polyadenylated at
its natural site. The A allele prothrombin variant was
more efficient than the G allele at promoting cleavage
at this site in the presence of a competing poly (A)
sequence. In the absence of competition, both allelic
variants give rise to a similar level of cleavage site
heterogeneity. An upstream sequence element (USE)
was also identified within the prothrombin 30-UTR.
When placed upstream of two competing poly (A)
sites, the USE directed cleavage preferentially to the
proximal poly (A) site. In the absence of competition,
the USE had no effect on cleavage siteselection. This
study suggests that the basis for the increase in pro-
thrombin expression in A allele carriers is not due to
allelic changes in cleavage site selection per se.I n
addition, the functionality of USEs needs to be con-
sidered within the context of endogenous sequence
architecture.
INTRODUCTION
Prothrombinisacentralregulatorycomponentofthecoagulation
cascade which in its active form, thrombin, performs both
procoagulant and anticoagulant roles (1). The prothrombin
G20210Apolymorphism is a singleGtoAnucleotidetransition
atthe30cleavagesiteofprothrombinpre-mRNAandisassociated
with increased levels of plasma prothrombin (2–6). Individuals
heterozygousfor this polymorphism havea three-fold increased
risk of developing venous thrombosis (2). The G20210A poly-
morphism is functional (7), however, the consequences of this
polymorphism on prothrombin gene expression are contro-
versial. Increased plasma prothrombin levels caused by the
mutant (A allele) variant have been associated with changes in
prothrombin pre-mRNA cleavage and polyadenylation, mRNA
stabilityandtranslation(8–11).Overthelastfewyearstherehas
beenincreasedemphasisonthefunctionalroleofthispolymorph-
ism at the level of prothrombin mRNA 30-end formation.
Speciﬁc sequence elements within the pre-mRNA direct
the binding of the 30 pre-mRNA processing complex to the
pre-mRNA, which in turn are necessary for cleavage and
polyadenylation (reviewed in 12,13). Typically, mammalian
30 pre-mRNA processing requires the conserved polyadeny-
lation signal (50-AAUAAA-30) located 10–30 nt upstream of
the cleavage site and a second less conserved element referred
to as the downstream sequence element (DSE), usually located
within 30 nt downstream of the cleavage site (12). Cleavage
does not occur at a consensus site, however a CA dinucleotide
is frequently found at the site of cleavage (14,15). A selected
number of pre-mRNAs contain additional elements that inﬂu-
ence 30 pre-mRNA processing efﬁciency besides AAUAAA
and DSE. One such element is located upstream of cleavage
sites and is referred to as the upstream sequence element
(USE). USEs are described as U-rich in sequence (12) and
have been predominately characterized in viruses such as
SV40, adenovirus, hepatitis B and HIV-1 pre-mRNAs (16–
19). More recently, functional USEs have been described in
cellular genes including complement factor C2, lamin B2,
collagen and 20-50-oligoadenylate synthetase enzyme (20–23).
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doi:10.1093/nar/gki245The efﬁciency and accuracy of an individual poly (A) site is
determinedbythe polyadenylationsignalitselfandtherelative
location of auxiliary sequences upstream and downstream of
the cleavage site. Bioinformatic analyses have revealed that
the efﬁciency of 30 pre-mRNA processing is not exclusively
mediated by the polyadenylation signal and DSE alone. Pre-
vious studies of polyadenylation sites revealed that  29% of
human genes have alternative poly (A) sites within one gene
and the usage of an alternative site is related to biological
conditions as opposed to being a random event (24,25).
Several studies on core elements suggested that while most
(50–60%) human polyadenylation sites contain the canonical
AAUAAA element, a large portion of genes have its single-
nucleotide variants, with AUUAAA as the most common
(24,26,27). DSEs do not have a consensus sequence and are
poorly characterized primarily due to the lack of cleavage-site
information. Graber and co-workers (26) identiﬁed U-rich/
UG-rich elements as DSEs, using about 4000 human and
6000 mouse expressed sequence tags. Zarudnaya et al. (28)
analysed 244 randomly selected human genes and proposed
the existence of auxiliary downstream elements that form
G-quadruplex structures in the SV40 late pre-mRNA
polyadenylation site as well as in a number of human genes.
Recently, Legendre and Gautheret (29) suggested that the
DSEs can be characterized as U-rich and probably do not
have any speciﬁc sequence elements. In their study, the
USE was also found to be U-rich; thus the cleavage site is
ﬂanked by U-rich sequences. Hence, the relative contribution
of the cis-elements involved in cleavage and polyadenylation
needs to be analysed on an individual transcript basis.
Recently, it has been demonstrated using a reporter gene
assay that the DSE of prothrombin is weak and it overcomes
this weakness with a functional USE (30). We have investig-
ated the role of the prothrombin USE in mRNA 30-end forma-
tion using full-length prothrombin mRNA expression vectors.
These vectors contain the full-length prothrombin cDNA and
downstream genomic sequence (DGS) to facilitate natural
prothrombin cleavage and polyadenylation. This model sys-
tem was used to assess the role of the USE in both a compet-
itive and non-competitive environment for mRNA 30-end
formation. If the USE was placed upstream of two competing
poly (A) sites, the USE acted to promote cleavage at the site
nearest the USE. Hence, the frequency of mRNA 30-end
formation at a given poly (A) sequence is enhanced in the
presence of a functional USE. In the absence of competition,
the prothrombin USE had no effect on pre-mRNA 30-end
formation at the level of cleavage site selection but was
shown to slightly reduce mRNA expression levels when
mutated. Our results also show that the G20210A polymorph-
ism does not signiﬁcantly inﬂuence cleavage site selection.
Hence, the basis for the increase in plasma prothrombin
expression in A allele prothrombin carriers appears to be unre-
lated to the selection of the cleavage site per se, but related to
other aspects of prothrombin mRNA metabolism.
MATERIALS AND METHODS
Construction of prothrombin expression plasmids
containing mutated SV40 polyadenylation signal
To assess the functional role of the G20210A polymorphism
we designed constructs that generated the full-length pro-
thrombin mRNA using downstream prothrombin genomic
sequences to direct natural 30-end formation. This was per-
formed using plasmid pCMV-PT-WT (9) as a template. This
construct contains the full-length wild-type (G allele) pro-
thrombin cDNA under the control of the CMV promoter
and the mRNA derived from this vector is 30 processed
using the SV40 polyadenylation sequence (9). The SV40 poly-
adenylation signal AAUAAA was mutated to GCGCGA by
overlap extension mutagenesis PCR (31) using primers (SJS
009, SJS 014, SJS 015 and SJS 016; see Table 1) with the
Table 1. PCR amplification primers
Primer Nucleotide sequence Orientation GenBank reference
SJS 009 50-TGAAGAAGTGGATACAGAAGG-30 Forward (1807–1827 PT cDNA)
SJS 010 50-CTGGTTACAAGCCTGATGAAG-30 Forward (1632–1653 PT cDNA)
SJS 013 50-GGTACGAGCGAAACATTGAAAAGATAT-30 Forward (1278–1305 PT cDNA)
SJS 014 50-GGGCGAAAAACCGTCTATCAGGG-30 Reverse (1727–1750 pCI-Neo)
SJS 015 50-CCATTATAAGCTGCGCGCGACAAGTTAACAAC-30 Forward (1271–1300 pCI-Neo)
SJS 016 50-GTTGTTAACTTGTCGCGCGCAGCTTATAATGG-30 Reverse (1271–1300 pCI-Neo)
SJS 017 50-ATAACATGCGGCCGCTTCCTGAGCCCAGAGAGCT-
GCCCATGAATAGCACTGGGAGCATTGAGGCTCGCTG-
AGAGTCACTTTTATTG-30
Reverse (26764–26844 PT
genomic)
SJS 018 50-ATAACATGCGGCCGCTTCCTGAGCCCAGAGAGC-
TGCCCATGAATAGCACTGGGAGCATTGAGGCTTG-
CTGAGAGTCACTTTTATTG-30
Reverse (26764–26844 PT
genomic)
SJS 025 50-GCAGCATCGAGGCACTAAAACTATGG-30 Forward (1897–1922 PT cDNA)
SJS 026 50-AGTGCCTCGATGCTGCTTCTTTCACGG-30 Reverse (1886–1902 PT cDNA)
SJS 056 50-TTTATAGCGGCCGCTGCTGAGAGTCACT-30 Reverse (1934–1947 PT cDNA)
SJS 069 50-CGGATGGAAGCCGGTCTTGT-30 Forward (2901–2920 pCI-Neo)
SJS 089 50-ATAAGAATGCGGCCGCAAGTAAAACCTCTACAAATG-30 Forward (1364–1382 pCI-Neo)
SJS 090 50-GTCGGGGCTGGCTTAAC-30 Reverse (3434–3450 pCI-Neo)
SJS 125 50-GCGATAGAAGGCGATGCGCT-30 Reverse (3217–3236 pCI-Neo)
Nest 13 FNest 50-TGCCTGTGAAGGTGACAGTG-30 Forward (1667–1686 PT cDNA)
Nest 13F.1 50-ACCCTTTGTCATGAAGAGCC-30 Forward (1690–1710 PT cDNA)
The name, nucleotide sequence, orientation and GenBank nucleotide reference are provided. The mutations within the sequence are underlined and the restriction
enzyme sites are italicized. Prothrombin cDNA (accession no. V00595), prothrombin genomic sequence (accession no. M17262) and pCI-Neo vector (Promega).
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and NotI located within the vector sequence).
To generate the A allele variant of this construct, the G
allele prothrombin cDNA was ﬁrst removed from the
SV40-mutated vector by Sal1 and Not1 digestion, and
replaced with the A allele variant prothrombin cDNA that
had been excised from plasmid pCMV-PT-MUT (9) using
the same restriction enzymes. The plasmids generated by
this procedure are shown schematically in Figure 1B and
are listed below:
PT-G: wild-type (G allele) prothrombin cDNA containing
mutated SV40 polyadenylation site.
PT-A: mutant (A allele) prothrombin cDNA containing
mutated SV40 polyadenylation site.
Introduction of DGS into plasmid pPT-G/A
A 50 bp genomic prothrombin sequence (position 26785–
26844 accession no. M17262) downstream of the prothrombin
mRNA cleavage site was introduced into the modiﬁed allelic
prothrombin expression plasmids (above). This was generated
by PCR using mega-primers (G and A allele variants) con-
taining the 50 bp genomic sequence (primers SJS 017 and SJS
018, respectively), and an upstream primer (SJS 010) that
incorporated the Bcl1 site within the prothrombin 30-untrans-
lated region (30-UTR). The mega-primer contained a Not1 site
at the 30 end (the terminal cloning site of prothrombin). Diges-
tion of the PCR product with Bcl1 and Not1 enabled subclon-
ing of 50 bp DGS juxtaposed to the prothrombin cleavage site
within PT-G and PT-A. The plasmids generated from these
manipulations are shownschematically in Figure 1Band listed
below:
PT-G-DGS: wild-type (G allele) prothrombin cDNA con-
taining mutated SV40 polyadenylation signal and 50 bp of
DGS.
PT-A-DGS: mutant (A allele) prothrombin cDNA contain-
ingmutatedSV40polyadenylationsignaland50bpofDGS.
Figure 1. Prothrombin mRNA is cleaved and polyadenylated in the absence of DGS. (A)3 0RACE results of RNA isolated from cells stably transfected with
prothrombinallelic variants.Lane 1, 100 bp DNA ladder;lane 2, Endogenousprothrombin mRNA detectedin HepG2 cells; lane 3, HEK-293cells transfected with
the pCI-Neo vector (con); lanes 4 and 5, HEK-293 cells expressing wild-type (pCMV-PT-WT) or mutant (pCMV-PT-MUT) prothrombin variants, respectively,
using the SV40 polyadenylation signal. (B) Schematic representation of the constructs expressing prothrombin variants. All constructs express the full-length
prothrombin cDNA including the entire 30-untranslated region (30-UTR) under the control of the CMV promoter. Cleavage and polyadenylation elements involved
in prothrombin 30-end formation are indicated: USE, upstream sequence element; DGS, 50 bp downstream genomic sequence; AAUAAA, polyadenylation signal;
CG/CA, polymorphic cleavage site. All constructs contain mutations within the SV40 polyadenylation signal (AAUAAA mutated to GCGCGA): PT-G/A, allelic
prothrombincDNAwithnoDGS;PT-G/A-DGS,prothrombinvariantcDNAwith50bpofDGS.(C)3 0RACEresultsofRNAisolatedfromHEK-293cellstransiently
transfected with prothrombin allelic variants containing mutations within the SV40 poly A signal, with or without the DGS of prothrombin. Lane 1, 100 bp DNA
ladder;lane2,HEK-293cellstransfectedwiththepCI-Neovector(con),lane3,PT-G;lane4,PT-G-DGS;lane5,PT-Aandlane6,PT-A-DGS.The50 cleavagesite
represents mRNA produced using the natural prothrombin cleavage site. The slower migrating band (30 cleavage site) depicts the cryptic downstream cleavage site
within the vector sequence. Neomycin phosphotransferase (Neo) mRNA was used as a measure of transfection efficiency (lower panel).
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prothrombin USE
TheprothrombinUSE(TTATTTTTGTGTTT,seeResults)was
mutated to GCAGCATCGAGGCA by overlap mutagenesis
PCR using plasmid pPT-G as a template. This was performed
using primers harbouring the relevant base substitutions
within the USE (SJS 025 and SJS 026) and external primers
SJS 013 and SJS 014 that included restriction enzymes EcoRV
(located 50 of the prothrombin USE) and NotI, respectively.
The resulting plasmid was referred to as PT-G-USEmut. The
A allele prothrombin variant containing a mutated USE
(PT-A-USEmut) was generated using primers SJS 013 and
SJS 056 (the latter primer introduces the A residue at the
poly (A) site and a NotI restriction site at the 30 end) and
PT-G-USEmut as the template. Following this, the DGS
was introduced into these plasmids using the strategy outlined
above. The plasmids generated from these manipulations are
listed below and shown schematically in Figure 4A:
PT-G-USEmut: wild-type (G allele) prothrombin cDNA
containing mutated SV40 polyadenylation signal and
mutated prothrombin USE.
pPT-A-USEmut: mutant (A allele) prothrombin cDNA
containing mutated SV40 polyadenylation signal and
mutated prothrombin USE.
PT-G-DGS-USEmut: wild-type (G allele) prothrombin
cDNA containing mutated SV40 polyadenylation signal
and mutated prothrombin USE with 50 bp of DGS.
PT-A-DGS-USEmut:mutant(Aallele)prothrombincDNA
containing mutated SV40 polyadenylation signal and
mutated prothrombin USE with 50 bp of DGS.
Generation of plasmids containing complete deletion
of the SV40 poly (A) sequence
To remove the cryptic cleavage site within the SV40 poly-
adenylation sequence (see Results), the 226 bp late SV40
polyadenylation sequence (1137–1363 bp) within the pCI-
Neo vector (Promega) was deleted. The vector was ﬁrst diges-
ted with Not1 and BamH1. This removed a 2.0 kb region that
included the SV40 polyadenylation sequence, neomycin res-
istance gene (neo) and the f1 origin of replication (f1 ori). To
replace the region containing Neo and f1 ori, a PCR strategy
was adopted. To this end, the region from 1364 to 3350 of pCI-
Neo (that excludes the SV40 polyadenylation sequence) was
ampliﬁed by PCR using upstream primer SJS 089 (located 30
of the SV40 polyadenylation sequence and incorporating a
Not1 site at the 30end) and downstream primer SJS 090
(located 30 of BamHI site within the vector). The resulting
product was digested with BamHI and NotI and subcloned into
the appropriate site within the pCI-Neo vector to create
pCIDSV40. Note the pCIDSV40 vector retains the pCI-Neo
multiple cloning sites. All prothrombin variants were then
subcloned into pCIDSV40 using the SalI and NotI restriction
sites within the multiple cloning site. These plasmids are
shown schematically in Figure 6A.
Generation of plasmids containing tandem
prothrombin polyadenylation sequences
ThepCIDSV40vectorwasusedtogenerateaprothrombinexp-
ression plasmid containing tandem copies of the prothrombin
polyadenylation sequence (that included the DGS). The
prothrombin cDNA (harbouring one copy of the 30-UTR
and DGS) was initially subcloned into the SalI and SmaI
sites of pCIDSV40. The second copy of the prothrombin poly-
adenylation sequence was introduced into the above construct
using SmaI and NotI restriction sites. The tandem arrangement
of the polyadenylation sequences in plasmid pCIDSV40 is
shown schematically in Figure 5A.
Cell culture and transfection
Human HEK-293 cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Invitrogen), supplemented with
10% (v/v) heat-inactivated foetal bovine serum (HI-FBS),
2mM glutamine, and streptomycin and penicillin, in a humidi-
ﬁed atmosphere at 37 C with 5% CO2. Constructs were trans-
fected transiently by calcium phosphate precipitation using
5 mg plasmid DNA in a 60 mm dish as previously described
(32), except the transfection mixture was incubated with the
cells for 16 h and the glycerol shock was omitted (33). Fresh
DMEM containing 10% HI-FBS was then added and cells
were maintained for a further 48 h. Total RNA was extracted
for further analysis. Stable cell lines were generated by select-
ing with 1000 mg/ml G418 (Life Technologies, Inc.) and
pooling resistant clones.
RNA extraction and 30RACE
Total RNA was extracted from cells as described pre-
viously (34). The quality of each RNA sample was conﬁrmed
by agarose-gel (1%) electrophoresis. cDNA synthesis was
performed by 30 rapid ampliﬁcation of cDNA ends (30RACE)
(Invitrogen Life Technologies). 2 mg of RNA was used for ﬁrst
strand cDNA synthesis. A nested PCR method was performed
to determine the cleavage/polyadenylation site of prothrombin
mRNA. 2 ml of the ﬁrst strand cDNA synthesis was used to
amplify prothrombin cDNA sequences by PCR using the Ex
13F Nest primer (Table 1) and reverse primer AUAP (30RACE
kit). Hot start PCR was performed in which Taq polymerase
was added after incubation of the reaction for 5 min at 94 C.
Thermal cycling was carried out after preincubation at 94 C
for 3 min, 25 cycles of denaturation at 94 C for 30 s, annealing
at58 Cfor30sandextensionat72 Cfor1minandaﬁnal step
at 5 min at 72 C. About 2 ml of 1 in 100 dilution of the above
PCR reaction was used as a template for the nested PCR.
The second PCR was performed using primer Ex 13F.1
Nest (Table 1) and the same reverse primer as used for the
ﬁrst PCR. Thermal cycling was carried out in a similar fashion
to the ﬁrst PCR except 35 cycles were performed with an
annealing temperature of 65 C. Neomycin phosphotransferase
(Neo) mRNA was detected using 2 ml of ﬁrst stand reaction
and primers SJS 069 and SJS 125. Thermal cycling was
performed as above (25 cycles) with an annealing temperature
of 65 C. PCR products were resolved on 2% agarose gels
and visualized on a transilluminator using ethidium bromide.
To assess PCR products for speciﬁcity and to evaluate
position of the polyadenylation site, the products were
excised from the gel and cloned into pGEM-T Easy vector
(Promega). Positive clones were sequenced using the universal
T7 primer.
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The ribonuclease (RNase) protection assay was carried out
using the RPA III kit (Ambion) with 10 mg of total RNA
prepared from transiently transfected HEK-293 cells. RNA
samples were subjected to DNase-1 digestion (Promega)
prior to use. The prothrombin RNA probe was 250 nt in length
directed against region 1643–1889 within the prothrombin
cDNA (accession no. V00595). The Neo probe was 200 nt
in length directed towards position 2472–2680 within the pCI-
Neo vector. To generate these RNA probes, prothrombin and
Neo cDNA fragments were ﬁrst subcloned into the pGEM-T
Easy vector and then linearized with SacII. The probes were
in vitro transcribed using SP6 RNA polymerase. The products
were resolved on a denaturing gel (7M urea/5% polyacrylam-
ide gel) and visualized by autoradiography (Kodak BioMax
ﬁlm). Signals were quantitated using ImageQuant Version 5
(AmershamBiosciences)andtheresultspresentedingraphical
form after correcting for changes in Neo mRNA expression
between samples.
Statistical analyses
Results are expressed as the mean – standard error of the mean
(SEM) and analyses were performed by two-sample one tailed
Students t-test. P-value <0.05 was considered as signiﬁcant.
RESULTS
Prothrombin mRNA is able to cleave and polyadenylate
at its natural position in the absence of DGS
Previously, Carter and co-workers (9) generated the full-
length prothrombin mRNA using the vector derived SV40
polyadenylation signal (pCMV-PT-WT/MUT). To conﬁrm
the position of the 30 cleavage site, these constructs were
ﬁrst transfected into HEK-293 cells and the 30 cleavage site
of prothrombin mRNA was determined by 30RACE and
sequencing. As shown in Figure 1A (lanes 4 and 5), the G
and A allelic prothrombin transcripts generated using the
SV40 polyadenylation signal (pCMV-PT-WT/MUT) produce
a single product that is  200 nt longer than the endogenous
prothrombin expressed in Hep G2 cells (Figure 1A, lane 2).
Sequence analysis conﬁrmed that cleavage occurred at the
SV40 polyadenylation site. This difference, as expected, is
fully accounted for by vector-derived sequences.
To assess the functional role of the G20210Apolymorphism
atthelevelof30 pre-mRNAprocessing,wedesignedconstructs
that generated full-length prothrombin mRNA that was
cleaved and polyadenylated at its natural site. To achieve
this, the highly efﬁcient SV40 polyadenylation signal within
pCMV-PT-WT/MUT vectors was inactivated via mutation
(Figure 1B, PT-G/A). In addition to the polyadenylation sig-
nal, 30 pre-mRNA processing also requires DSEs usually loc-
ated within 30 nt of the cleavage site (12). Therefore, 50 bp of
prothrombin DGS was introduced into the vectors containing
the mutated SV40 polyadenylation signal to direct natural
prothrombin mRNA 30-end formation (Figure 1B). These pro-
thrombin constructs were transfected into HEK-293 cells
and prothrombin mRNA expression and the 30 cleavage site
selection was analysed by 30RACE and DNA sequencing.
30RACE results of RNA from HEK-293 cells transfected
with the prothrombin expression constructs containing the
mutated SV40 polyadenylation signal are shown in
Figure 1C. In the absence of both the SV40 polyadenylation
signal and downstream prothrombin genomic sequences, both
allelic prothrombin expression plasmids (PT-G/A) were able
to generate transcripts with cleavage occurring at two sites.
The identical pattern was seen for both the A and G allele
prothrombin variants (Figure 1C, lanes 3 and 5). Sequencing
analysis revealed that the 50 cleavage site was occurring at the
natural prothrombin cleavage site, while the unexpected 30 site
was located within the vector derived-sequence, upstream of
the mutated SV40 polyadenylation signal (Figure 2). The faint
larger product just above the 30 cleavage site is the result of
the low level of cleavage at the SV40 site (Figure 3C). In
principle, the mutated SV40 signal is deactivated, however,
we cannot exclude the occurrence of rare cleavage events that
are detected by the sensitivity of the PCR technique.
The molecular basis for the selection of the cryptic 30 cleav-
age site is presently unknown but may possibly be due to a
variant polyadenylation signal or secondary structure. How-
ever, the fact that some cleavage was occurring at the natural
position even in the absence of downstream sequences sug-
gests that the prothrombin transcript contains functionally
relevant cis-acting elements upstream of the cleavage site
to direct the cleavage machinery to the correct location.
Introduction of 50 bp of DGS resulted in an allele-speciﬁc
alteration in the cleavage site selection (Figure 1C, lanes 4
and 6). Plasmids expressing the wild-type (G allele) prothrom-
bin variant produced transcripts that utilized the same two
cleavage sites, one occurring at the natural position, and the
other at the cryptic site. In contrast, plasmids expressing the
mutant (A allele) prothrombin produced transcripts that were
cleaved at the natural position, with only a small percentage of
transcripts being cleaved at the cryptic 30 position. Hence, the
A allele variant is stronger than the G allele at maintaining
cleavage at the prothrombin poly (A) sequence.
An upstream element in the prothrombin 30-UTR
influences selection of the 30 cleavage site
Results presented in Figure 1C (lanes 3 and 5) provide evid-
ence that prothrombin mRNA contains a functional upstream
sequence that inﬂuences the selection of the cleavage site.
Such USEs within the 30-UTR have been described in only
a few mammalian genes, and in these cases, the identiﬁed USE
wasshowntobehighlyU-rich.Close analysisoftheprothrom-
bin 30-UTR revealed the presence of a putative U-rich USE
located 17 nt from the natural prothrombin polyadenylation
signal (Figure 2). Comparison of the human prothrombin tran-
script with the prothrombin sequence derived from rabbit,
bovine, mouse and rat revealed that this USE was highly
conserved (Figure 3) which is suggestive of functional relev-
ance. To determine if the USE plays a role in prothrombin
30-end formation, a 14 bp substitution (Figure 2) was
introduced into this region within the SV40 polyadenylation
signal-inactivated plasmids (Figure 4A). 30RACE analysis of
HEK-293 cells transfected with these expression constructs
revealed that the natural cleavage site was rarely used and
the cleavage site was moved to the downstream cryptic posi-
tion for both allelic constructs (Figure 4B, lanes 4 and 7).
1014 Nucleic Acids Research, 2005, Vol. 33, No. 3Furthermore, removal of the genomic downstream sequences
from these constructs resulted in all transcripts being 30cleaved
at the cryptic site within the vector (Figure 4B, lanes 5 and 8).
Taken together, these data indicate that a functional USE
within the prothrombin 30-UTR inﬂuences the selection of
the 30 cleavage site.
The USE is functional in the presence of tandem
prothrombin poly (A) signals
The constructs containing an inactivated SV40 polyadenyla-
tion signal possessed a cryptic cleavage site within the SV40
poly (A) sequence which competed with the natural pro-
thrombin cleavage site (Figure 1C). To assess the role of
the USE in an environment in which the competing poly(A)
signals are of similar strength, we removed the cryptic 30
Figure 2. Schematic representation and nucleotide sequence of prothrombin variants expressed using the vectors harbouring the mutated SV40 polyadenylation
signal. Indicated in the figure: the mutated prothrombin upstream sequence element (USEmut); AAUAAA, prothrombin (PT) polyadenylation signal; CG/CA,
prothrombin polymorphic cleavage site; 50 bp prothrombin downstream genomic sequence (DGS); cryptic 30 cleavage site; mutated SV40 polyadenylation signal
(gcgcgA);SV40cleavage site,AC.Duetothepresenceofadenineresiduesdownstreamoftheindicatedcryptic(1–3nt)andSV40(1–2nt)sites,itisnotpossibleto
ascertaintheexactsiteofcleavagebysequencingduetothepresenceofthepoly(A)tail.Forsimplicityonlythelastnon-adenineresidueisindicatedasthepositionof
the cryptic and SV40 cleavage sites.
Figure 3. Prothrombin USE is highly conserved in sequences derived from
other mammalian species. Comparison of the prothrombin USE within
mammalian species; human (accession no. V00595), mouse (accession no.
M81394), rat (accession no. M81397), rabbit (accession no. M81396) and
bovine (accession no. NM 173877). Asterisks indicate the conserved
nucleotides between the mammalian species.
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adenylation sequence (i.e. DSV40) and incorporated a tan-
dem copy of the full-length G allele variant of the
prothrombin 30-UTR and DGS (Figure 5A). These plasmids
were transfected into HEK-293 cells and 30RACE was per-
formed to assess the preferred sites of cleavage. As shown in
Figure 5B, both cleavage sites are utilized in the presence of
tandem repeat sequences with unaltered USE and DSE, with
cleavage favouring the poly (A) site within the ﬁrst repeat
[i.e. poly (A) site 1] (lane 2). When the USE was selectively
mutated within poly (A) site 1 of the 30-UTR, poly (A) site 2
was preferred (lane 3). In the reverse experiment, mutation
of the USE within poly (A) site 2 forced cleavage to occur at
poly (A) site 1 (lane 4). When the USE was mutated within
both poly (A) sites, cleavage appeared to occur favourably at
poly (A) site 1 (lane 5), similar to the pattern seen for the
wild-type tandem transcript (lane 2). These results demon-
strate that frequency of 30-end formation of a given poly (A)
signal within a competitive environment is enhanced in the
presence of a functional USE.
The prothrombin G20201A and the USE do not
impact on cleavage site selection in the absence of
competition
It was important to assess the role of the USE in a non-
competitive environment. To assess this, prothrombin
expression constructs containing a single copy of the pro-
thrombin 30-UTR and DGS (i.e. the native conﬁgura-
tion) were expressed using vectors (pPT-G/A-DSV40,
Figure 6A). The DSV40 constructs were transiently transfec-
ted into HEK-293 cells and the cleavage site was determined
by 30RACE and sequencing. The precise position of the
cleavage site of the prothrombin mRNA cannot be accurately
determined after the addition of a poly (A) tail since an A
residue is present at position 20211 within the gene. Hence,
the cleavage site for the G allele prothrombin mRNA variant
can occur at 20210G or 20211A, whereas the A allele variant
cleavage could occur at 20209C, 20210A or 20211A. Here,
we have deﬁned the CG (G allele) or CA (A allele) dinuc-
leotide preceding the poly (A) tail as being cleaved at posi-
tion 20210. In the absence of any competing downstream
cleavage site, both prothrombin variants (G and A allele)
produced a single transcript with a size consistent with the
natural cleavage site (Figure 6B). Indeed, mutagenesis of the
USE had little effect on prothrombin mRNA production
(Figure 6B, compare lanes 2 with 3 and 6 with 7) and did
not inﬂuence cleavage site selection. All transcripts contain-
ing either the G or A allelic variant with or without an intact
USE produced a similar heterogeneous population of tran-
scripts (Figure 6C). This data indicates that neither the
G20210A polymorphism nor the USE inﬂuence selection
of the cleavage site in the absence of competition in this
model system.
Figure 4. USE in prothrombin 30-UTR influences the selection of the natural prothrombin cleavage site. (A) Schematic representation of the constructs expressing
prothrombin variants. All constructs express the full-length prothrombin cDNA including the entire 30-UTR under the control of the CMV promoter. Cleavage and
polyadenylation elements involvedin prothrombin 30-end formationare indicated: USE, upstreamsequence element; DGS, 50 bp downstream genomic sequences;
AAUAAA, polyadenylation signal; CG/CA, polymorphic cleavage site. All constructs contain mutations within the SV40 polyadenylation signal (AAUAAA
mutated to GCGCGA): PT-G/A-DGS, prothrombin variant cDNA with 50 bp of DGS; PT-G/A-USEmut, prothrombin variant cDNA with mutated USE; PT-G/A-
USEmut-DGS,prothrombinvariantcDNAwith50bpDSGandmutatedUSE.(B)3 0RACEresultsofRNApreparedfromHEK-293cellstransientlytransfectedwith
prothrombinallelicvariantscontainingmutationswithintheSV40polyAsignal,withorwithouttheDGSand/orUSE ofprothrombin.Lane1,100 bpDNAladder;
lane2,HEK-293cellstransfectedwiththepCI-Neovector(con);lane3:PT-G-DGS;lane4:PT-G-USEmut-DGS;lane5,PT-G-USEmut;lane6,PT-A-DGS;lane7,
PT-A-USEmut-DGSandlane8,PT-A-USEmut.The50 cleavagesiterepresentsmRNAproducedusingthenaturalprothrombincleavagesite.Theslowermigrating
band (30 cleavage site) depicts the cryptic downstream cleavage site within the vector sequence. Neo mRNA was used as a measure of transfection efficiency
(lower panel).
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To determine whether the USE either alone or in combination
with the DGS could affect amount of prothrombin mRNA
production, RNase protection assays were undertaken on
total RNA from cells transfected with prothrombin G allele
variants containing mutations/deletions in either or in both
elements. Mutagenesis of the USE or the removal of DGS
(either alone or in combination) resulted in a reduction in
levels of prothrombin mRNA (Figure 7). However, since
the majority of prothrombin mRNA expression is maintained
in the absence of both the USE and the DGS, it implies that
other elements within the prothrombin 30-UTR are critical for
maximal mRNA production.
DISCUSSION
The molecular function of the prothrombin G20210A poly-
morphism has been associated with various aspects of gene
regulation including mRNA 30-end formation, stability and
translation (8–11,35). In general, the polymorphism appears
to have a critical effect at the level of mRNA 30-end formation.
Using a reporter gene system it was demonstrated that the A
allele transcript of prothrombin promotes increased efﬁciency
of cleavage and polyadenylation compared to the G allele
(8,10). Additionally, the A allele of prothrombin has been
found to give rise to a homogeneous population of transcripts
in contrast to the G allele in vivo (using liver tissue) and
in vitro (using a reporter gene system) (11,35). Here, we
have assessed the role of the G20210A polymorphism and
30-end formation within the context of the full-length
prothrombin mRNA.
The full-length prothrombin mRNA was ﬁrst generated
using mammalian expression vectors with the SV40 poly-
adenylation signal mutated containing the complete prothrom-
bin cDNA and 50 bp of the DGS. The DGS was included to
provide prothrombin with its DSE which is necessary for
mRNA30-end formation. These constructs,with an inactivated
SV40 polyadenylation signal generated transcripts with two
cleavage sites; one occurring at the natural prothrombin poly
(A) site and the other at an unforeseen 30 distal cleavage site,
located within the SV40 vector-derived sequence. The cryptic
30 distal cleavage site was upstream of the mutated SV40
polyadenylation signal. This phenomenon was not speciﬁc
for HEK-293 cells as it was reproduced in transfected NIH
Figure 5. TheUSEisfunctionalinthepresenceoftandemprothrombinpoly(A)signals.(A)Schematicrepresentationofconstructsexpressingthefull-lengthwild-
type(Gallele)prothrombinmRNAwithtandemarrangementofthe30-UTRandDGSindicatedaspoly(A)site1andpoly(A)site2.Allconstructscontaina9ntspace
between the tandem repeats. Cleavage and polyadenylation elements involved in prothrombin 30-end formation are indicated: USE, upstream sequence element;
DGS, 50 bp downstream genomic sequences; AAUAAA, polyadenylation signal; CG, wild-type cleavage site. The SV40 polyadenylation sequence (DSV40) has
beenremovedfromallconstructs:PT-G-G,prothrombincDNAwithtandempoly(A)sites(polyAsites1and2);PT-G-USEmut-G,containsmutationofUSEwithin
poly (A) site 1; PT-G-G-USEmut, contains mutation of USE within poly (A) site 2; PT-G-USEmut-G-USEmut-DGS, contains mutation of the USE within poly A
sites 1 and 2. (B)3 0RACE results of RNA from cells transfected with the tandem prothrombin polyadenylation sequence (30-UTR + DGS). Lane 1, 100 bp DNA
ladder; lane 2, PT-G-G; lane 3, PT-G-USEmut-G; lane 4, PT-G-G-USEmut and lane 5, PT-G-USEmut-G-USEmut. The table below represents the quantitation
(Image Quant) of the bands generated by prothrombin mRNA expression using poly (A) site 1 (50) and 2 (30) – standard error of the mean (n = 3). The quantitation
was corrected for fragment size.
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inﬂuence the ability of DSEs to promote cleavage and poly-
adenylation (28,36). We suspect that a secondary structure
formed within the pre-mRNA generated from these constructs
optimally positions the cryptic site for cleavage using the
prothrombin polyadenylation signal. However, it is equally
likely that cleavage isoccurring usingan unconventional poly-
adenylation signal (37). For instance the SV40 polyadenyla-
tion signal (AAUAAA) when mutated to AAAAAA retained
 5% polyadenylation efﬁciency in vitro (14). We have
observed the presence of a stretch of AAAAAA located
13 nt upstream of the cryptic cleavage site which, when
combined with the U-rich element (4 out of 5 U tract)
located 19 nt downstream (refer to Figure 2 in Results),
may facilitate the cleavage at this site. Four out of ﬁve U
residues located within 6–25 nt downstream of the late
SV40 polyadenylation signal were sufﬁcient to mediate 30
pre-mRNA processing (38).
The production of two cleavage sites by vectors containing
the inactivated SV40 polyadenylation signal provided a con-
venient competition assay to ascertain the cis- elements neces-
sary for cleavage atthe natural prothrombin mRNA site. These
constructs demonstrated that the CA dinucleotide (A allele)
at the cleavage site of prothrombin directs more efﬁcient
Figure 6. The prothrombin G20210A and the USE do not impact on cleavage site selection in the absence of competition. (A) Schematic representation of the
constructs expressing prothrombin variants. All constructs express the full-length prothrombin cDNA including the entire 30-UTR under the control of the CMV
promoter. Cleavage and polyadenylation elements involved in prothrombin 30-end formation are indicated: USE, upstream sequence element; DGS, 50 bp
downstream genomic sequences; AAUAAA, polyadenylation signal; CG/CA, polymorphic cleavage site. The SV40 polyadenylation sequence has been removed
fromallconstructs(DSV40):PT-G/A-DGS,prothrombinvariantcDNAwith50bpofDGS;PT-G/A-USEmut-DGS,prothrombinvariantcDNAwith50bpDSGand
mutated USE; PT-G/A, allelic prothrombin cDNA with no DGS; PT-G/A-USEmut, prothrombin variant cDNA with mutated USE. (B)3 0RACE results of RNA
prepared from HEK-293 cells transiently transfected with constructs expressing prothrombin allelic variants (with and without DGS and/USE) using vectors that
hadtheSV40polyadenylationsequenceremoved.Lane1,100bpDNAladder;lane2,PT-G-DGS;lane3,PT-G-USEmut-DGS;lane4,PT-G;lane5,PT-G-USEmut;
lane6,PT-A-DGS;lane7,PT-A-USEmut-DGS;lane8,PT-Aandlane9,PT-A-USEmut.Thesevectorsgenerateasingle30RACEproductrepresentingprothrombin
mRNA being cleaved at its natural position. (C) Schematic representation of the percentage usage of prothrombin cleavage sites (determined by sequencing)
generatedbytheaboveconstructs;(i)PT-G-DGSDSV40(n=20),(ii)PT-G-USEmut-DGSDSV40(n=20),(iii)PT-A-DGSDSV40(n=20)and(iv)PT-A-USEmut-
DGS DSV40 (n = 20). The polymorphic residue at position 20210 is shown in bold.
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(G allele). This supports the earlier observations from tandem
poly (A) signal competition assays (8,10) and extends the
evidence towards the functional importance of this poly-
morphism. This indirect competition assay also revealed
that the USE of prothrombin is required for efﬁcient
mRNA 30-end formation at its natural site. The importance
of a USE in mRNA 30-end formation was further evaluated
using constructs expressing prothrombin that had the entire
SV40 polyadenylation sequence removed. These constructs
generated transcripts that cleaved and polyadenylated only
at prothrombin’s endogenous poly (A) site.
Within this context, both variants of the prothrombin gene
produced a similar heterogenous mRNA population in HEK-
293 cells. This agrees with the data obtainedwithin the context
of a reporter gene system containing the prothrombin 30-UTR
and DGSs ( 70 nt) in Hep G2 cells (10). In contrast, homo-
genous transcript production by the A allele was previously
described in an in vivo study using liver tissue (11) and within
the context of the reporter gene system containing the terminal
region of the prothrombin gene which included the last two
exons, the last intron and the DGS (35). In this study, the
expression level of the reporter gene was further increased
by incorporating additional DGS ( 1 kb). It cannot be
excluded that these additional genomic sequences may be
required to promote homogenous prothrombin mRNA popu-
lation by the A allele. Splicing and polyadenylation events
are coupled at the level of terminal intron removal (39–41).
Our experimental system did not contain introns and thus
30 pre-mRNA processing was independent of any splicing
events. Therefore, the effect of splicing of the last intron in
cleavage site selection remains to be determined.
A recent study using reporter genes also demonstrated that
the USE of prothrombin inﬂuences the efﬁciency of cleavage
and polyadenylation when in a competitive environment (30).
We have demonstrated that the USE is indeed important for
prothrombin poly (A) site selection in a competitive environ-
ment, but whether competition occurs naturally is unknown.
However, it is interesting to note the presence of a potential
polyadenylation signal (AAUAAA) located 627 bp down-
stream of the AAUAAA found within the 30-UTR of the pro-
thrombin gene. If this downstream site is present within the
prothrombin pre-mRNA, the USE within the 30-UTR may be
required to ensure cleavage at the ﬁrst polyadenylation signal
and thus, prevent mRNA 30-end formation at this downstream
site.
Within the context of the full-length prothrombin cDNA,
the USE was shown to have a minor effect on levels of mRNA
expression as assessed by RNase protection assays, yet had no
inﬂuence on cleavage site selection. This suggests that the
prothrombin gene may have other positional elements within
its 30-UTR that promote efﬁcient pre-mRNA 30-end formation.
The inﬂuence of USEs on mRNA 30-end formation has been
often characterized using reporter gene approaches or in vitro
assays (20,30,42). Our study demonstrated the importance of
characterizing the role of USEs within its natural context to
gain a complete understanding of its role in mRNA 30-end
formation.
In conclusion, we have provided novel insights into pro-
thrombin gene expression by utilizing an experimental system
that generated full-length prothrombin mRNA which was
cleaved and polyadenylated at the natural cleavage site.
Within this context the prothrombin G20210A polymorphism
does not appear to impact on cleavage site selection.
This suggests that the G20210A polymorphism may mod-
ulate other aspects of gene regulation besides mRNA 30-end
formation.
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